UPDATE: CannEpil™ production has officially commenced
MGC Pharma
APRIL 4, 2018
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Thursday March 29 was a day of celebration on MGC Pharma’s timeline as we announced the commencement of production for the first batch of CannEpil™. CannEpil™?—?CBD-based treatment for people with Refractory Epilepsy?—?is the first product we’ve released to market.
Let's personalize your content